Featuring an interview with Dr Ezra Cohen, including the following topics:
- Spectrum of targetable mutations in thyroid cancer and impact on treatment selection (0:00)
- Comparative efficacy of TRK inhibitors in patients with thyroid cancer, including those with CNS disease (6:06)
- Current and emerging roles of immunotherapy alone and in combination with tyrosine kinase inhibitors for patients with head and neck cancer (10:17)
- Predicting clinical response to immunotherapy for patients with head and neck cancers (19:47)
- Role of dose reduction in managing toxicities associated with immunotherapy and targeted agents (26:01)
- Current and potential roles for cell-free DNA testing and minimal residual disease assessment in the management of head and neck cancer (32:08)
- Recently reported efficacy data with avasopasem in the treatment of radiation-induced oral mucositis (35:27)
- Factors affecting response to immunotherapy (42:07)
CME information and select publications
Research To Practice | Oncology Videos